Early detection of prostate cancer in African-American men through use of multiple biomarkers: human kallikrein 2 (hK2), prostate-specific antigen (PSA), and free PSA (fPSA)
Open Access
- 9 March 2004
- journal article
- research article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 7 (2) , 132-137
- https://doi.org/10.1038/sj.pcan.4500706
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Screening for Prostate Cancer in High Risk PopulationsJournal of Urology, 2002
- Comparative Analysis of Complexed Prostate Specific Antigen, Free Prostate Specific Antigen and Their Ratio in Detecting Prostate CancerJournal of Urology, 2002
- Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communitiesThe Prostate, 2002
- Improvements in pathologic staging for African-American men undergoing radical retropubic prostatectomy during the prostate specific antigen eraCancer, 2001
- COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCERJournal of Urology, 2000
- USE OF LOWER PROSTATE SPECIFIC ANTIGEN CUTOFFS FOR PROSTATE CANCER SCREENING IN BLACK AND WHITE MENJournal of Urology, 1998
- Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the ProstateCritical Reviews in Clinical Laboratory Sciences, 1998
- Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levelsUrology, 1997
- Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate ExaminationJAMA, 1997
- Characterization of the human kallikrein locusGenomics, 1992